Congress trading

Every stock trade disclosed by Congress

Every line of every STOCK Act report we hold, from House Clerk and Senate recordsEvery STOCK Act trade since 2014. Newest filing first, as of Nov 4, 2026; narrow the record by member, party, chamber, ticker, account or size, and every name and ticker opens its own page.

Filed in the last Asset More filters
Ticker AZNRemoveParty RepublicanRemoveFiled since 2014RemoveClear all

29 AZN trades by Republicans filed since 2014

Across 18 reports by 8 members · newest filing first · every Congress trade in the stock is on AstraZeneca's page

Sizes are the dollar ranges members report, never an exact amount. How to read the cards.

Since the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.

  1. Alan ArmstrongRepublican · Senate · OK
    Filed Jul 21, 20262 matching trades
    • bought AZN AstraZeneca
      Traded Mar 31, 2026 · disclosed 112 days later
      $1,001 - $15,000
      Since the trade-5.4% since the tradeEstimated entry price $197.22, close on Tue Mar 31Current price $186.58, close on Mon Nov 2
    • bought AZN AstraZeneca
      Traded Mar 30, 2026 · disclosed 113 days later
      $15,001 - $50,000
      Since the trade-3.8% since the tradeEstimated entry price $193.88, close on Mon Mar 30Current price $186.58, close on Mon Nov 2
  2. Julia LetlowRepublican · House · LA
    Filed Jan 13, 2026one matching trade, on a report of 224 trades
    • bought AZN AstraZeneca
      Traded Dec 8, 2025 · disclosed 36 days later
      $1,001 - $15,000
      Since the trade+3.1% since the tradeEstimated entry price $90.47, close on Mon Dec 8, 2025$180.94 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
  3. Lisa C. McClainRepublican · House · MI
    Filed Nov 21, 20253 matching trades
    • sold AZN AstraZeneca Spouse
      Traded Oct 31, 2025 · disclosed 21 days later
      $1,001 - $15,000
      Since the trade+13.2% since the saleEstimated exit price $82.40, close on Fri Oct 31, 2025$164.80 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
    • bought AZN AstraZeneca Spouse
      Traded Oct 30, 2025 · disclosed 22 days later
      $1,001 - $15,000
      Since the trade+13.3% since the tradeEstimated entry price $82.34, close on Thu Oct 30, 2025$164.68 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
    • sold AZN AstraZeneca Spouse
      Traded Oct 30, 2025 · disclosed 22 days later
      $1,001 - $15,000
      Since the trade+13.3% since the saleEstimated exit price $82.34, close on Thu Oct 30, 2025$164.68 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
  4. Lisa C. McClainRepublican · House · MI
    Filed Aug 13, 20253 matching trades
    • bought AZN AstraZeneca Spouse
      Traded Jul 22, 2025 · disclosed 22 days later
      $1,001 - $15,000
      Since the trade+31.5% since the tradeEstimated entry price $70.95, close on Tue Jul 22, 2025$141.90 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
    • sold AZN AstraZeneca Spouse
      Traded Jun 17, 2025 · disclosed 57 days later
      $1,001 - $15,000
      Since the trade+32.3% since the saleEstimated exit price $70.49, close on Tue Jun 17, 2025$140.98 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
    • bought AZN AstraZeneca Spouse
      Traded Jun 9, 2025 · disclosed 65 days later
      $1,001 - $15,000
      Since the trade+27.3% since the tradeEstimated entry price $73.26, close on Mon Jun 9, 2025$146.52 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
  5. Bruce WestermanRepublican · House · AR
    Filed May 12, 2025one matching trade
    • sold AZN AstraZeneca
      Traded Apr 21, 2025 · disclosed 21 days later
      $1,001 - $15,000
      Since the trade+40.9% since the saleEstimated exit price $66.19, close on Mon Apr 21, 2025$132.38 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
  6. Bruce WestermanRepublican · House · AR
    Filed Apr 16, 2025one matching trade
    • bought AZN AstraZeneca
      Traded Mar 3, 2025 · disclosed 44 days later
      $1,001 - $15,000
      Since the trade+23.4% since the tradeEstimated entry price $75.58, close on Mon Mar 3, 2025$151.16 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
  7. Michael T. McCaulRepublican · House · TX
    Filed Sep 14, 20232 matching trades
    • sold AZN AstraZeneca
      Traded Aug 14, 2023 · disclosed 31 days later
      $50,001 - $100,000
      Since the trade+30.3% since the saleEstimated exit price $71.60, close on Mon Aug 14, 2023$143.20 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
    • sold AZN AstraZeneca
      Traded Aug 14, 2023 · disclosed 31 days later
      $100,001 - $250,000
      Since the trade+30.3% since the saleEstimated exit price $71.60, close on Mon Aug 14, 2023$143.20 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
  8. Michael T. McCaulRepublican · House · TX
    Filed Aug 16, 20233 matching trades
    • sold AZN AstraZeneca
      Traded Jul 31, 2023 · disclosed 16 days later
      $15,001 - $50,000
      Since the trade+28.8% since the saleEstimated exit price $72.41, close on Mon Jul 31, 2023$144.82 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
    • sold AZN AstraZeneca
      Traded Jul 8, 2023 · disclosed 39 days later
      $50,001 - $100,000
      Since the trade+42.1% since the saleEstimated exit price $65.63, close on Mon Jul 10, 2023, the first after the Sat Jul 8, 2023 trade$131.26 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
    • sold AZN AstraZeneca
      Traded Jul 6, 2023 · disclosed 41 days later
      $15,001 - $50,000
      Since the trade+40.9% since the saleEstimated exit price $66.22, close on Thu Jul 6, 2023$132.44 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
  9. Michael T. McCaulRepublican · House · TX
    Filed Jun 22, 20232 matching trades
    • sold AZN AstraZeneca
      Traded May 2, 2023 · disclosed 51 days later
      $15,001 - $50,000
      Since the trade+27.7% since the saleEstimated exit price $73.08, close on Tue May 2, 2023$146.16 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
    • sold AZN AstraZeneca
      Traded May 2, 2023 · disclosed 51 days later
      $15,001 - $50,000
      Since the trade+27.7% since the saleEstimated exit price $73.08, close on Tue May 2, 2023$146.16 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
  10. Michael T. McCaulRepublican · House · TX
    Filed Jan 19, 2023one matching trade
    • sold AZN AstraZeneca
      Traded Dec 16, 2022 · disclosed 34 days later
      $1,001 - $15,000
      Since the trade+38.1% since the saleEstimated exit price $67.55, close on Fri Dec 16, 2022$135.10 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
  11. Michael T. McCaulRepublican · House · TX
    Filed Jun 14, 20222 matching trades
    • bought AZN AstraZeneca
      Traded Jun 5, 2022 · disclosed 9 days later
      $50,001 - $100,000
      Since the trade+48.6% since the tradeEstimated entry price $62.80, close on Mon Jun 6, 2022, the first after the Sun Jun 5, 2022 trade$125.60 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
    • bought AZN AstraZeneca
      Traded May 5, 2022 · disclosed 40 days later
      $50,001 - $100,000
      Since the trade+46.2% since the tradeEstimated entry price $63.80, close on Thu May 5, 2022$127.60 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
  12. Michael T. McCaulRepublican · House · TX
    Filed May 25, 20222 matching trades
    • bought AZN AstraZeneca
      Traded Apr 28, 2022 · disclosed 27 days later
      $100,001 - $250,000
      Since the trade+43.7% since the tradeEstimated entry price $64.92, close on Thu Apr 28, 2022$129.84 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
    • bought AZN AstraZeneca
      Traded Apr 28, 2022 · disclosed 27 days later
      $100,001 - $250,000
      Since the trade+43.7% since the tradeEstimated entry price $64.92, close on Thu Apr 28, 2022$129.84 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
  13. John H. RutherfordRepublican · House · FL
    Filed Jan 23, 2020one matching trade
    • sold AZN AstraZeneca
      Traded Jan 15, 2020 · disclosed 8 days later
      $1,001 - $15,000
      Since the trade+83.6% since the saleEstimated exit price $50.80, close on Wed Jan 15, 2020$101.60 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
  14. Shelley Moore CapitoRepublican · Senate · WV
    Filed Apr 17, 2019one matching trade
    • sold in full AZN AstraZeneca Spouse
      Traded Mar 11, 2019 · disclosed 37 days later
      $1,001 - $15,000
      Since the trade+128.4% since the saleEstimated exit price $40.85, close on Mon Mar 11, 2019$81.70 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
  15. John H. RutherfordRepublican · House · FL
    Filed Aug 20, 2018one matching trade
    • bought AZN AstraZeneca
      Traded Jul 11, 2017 · disclosed 405 days later
      $1,001 - $15,000
      Since the trade+180.7% since the tradeEstimated entry price $33.24, close on Tue Jul 11, 2017$66.48 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
  16. Shelley Moore CapitoRepublican · Senate · WV
    Filed Oct 6, 2017one matching trade
    • bought AZN AstraZeneca Spouse
      Traded Sep 8, 2017 · disclosed 28 days later
      $1,001 - $15,000
      Since the trade+192.9% since the tradeEstimated entry price $31.85, close on Fri Sep 8, 2017$63.70 in today's shares after a 1-for-2 reverse splitCurrent price $186.58, close on Mon Nov 2
  17. Michael T. McCaulRepublican · House · TX
    Filed Jun 10, 2014one matching trade
    • sold AZN AstraZeneca
      Traded May 1, 2014 · disclosed 40 days later
      $15,001 - $50,000
      Since the trade+128.4% since the saleEstimated exit price $81.70, close on Thu May 1, 2014Current price $186.58, close on Mon Nov 2
  18. Michael K. SimpsonRepublican · House · ID
    Filed May 3, 2014one matching trade
    • sold AZN AstraZeneca
      Traded Apr 25, 2014 · disclosed 8 days later
      $1,001 - $15,000
      Since the trade+175.4% since the saleEstimated exit price $67.75, close on Fri Apr 25, 2014Current price $186.58, close on Mon Nov 2

How to read the cards

  • One card: one report a member filed with the House Clerk or the Secretary of the Senate, newest filing first, its trades in date order. A trade the report lists twice, on the same day in the same range for two accounts, shows once here.
  • Size: the dollar range on the report, never an exact figure. A value that is not one of the STOCK Act's ranges prints as listed, and "Not captured" means the range is missing from our data.
  • Traded and disclosed: the trade date, then the days until the member disclosed it. The STOCK Act allows 45 days. The date filter counts from the filing date, not the trade date.
  • Since the trade: each priced line shows the estimated entry or exit price and the current price it is worked out from. Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. An option line reads n/a, because an option's premium is never disclosed; so does any other line that is not a stock, and a stock line whose closing prices we do not hold or whose prices failed our checks. Not investment advice.
  • Filed late: only on reports we checked against the House Clerk's copy, listed on the late filings page. A checked card links the original.
  • Long reports: 20 reports to a page. A report longer than 60 trades is shortened here, and so are the reports after a page passes 250 trades; the member's own page has every trade.